Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|ADDA 5||ADDA 5 is a non-competitive inhibitor of cytochrome c oxidase (CcO) that leads to growth inhibition in tumor cells (PMID: 27679486, PMID: 30143716).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||malignant glioma||not applicable||ADDA 5||Preclinical - Cell line xenograft||Actionable||In a preclinical study, ADDA 5 inhibited energy metabolism and proliferation in both chemo-sensitive and chemo-resistant glioma cell lines in culture, and suppressed tumor growth in cell line xenograft models (PMID: 27679486).||27679486|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|